The divergent role of two PRDM1 isoforms during human naïve pluripotency reprogramming [ATAC-seq]
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 31 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Samples
- 31 samples: 15 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE255859_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1077081 and SRA study SRP490038. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 31 samples.
How we read this: 15 replicated groups read from 31 sample titles; they account for 31 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8081769 ATAC-seq_hiF-T-1 ATAC-seq_hiF-T
- GSM8081770 ATAC-seq_hiF-T-2 ATAC-seq_hiF-T
- GSM8081771 ATAC-seq_2d-1 ATAC-seq_2d
- GSM8081772 ATAC-seq_2d-2 ATAC-seq_2d
- GSM8081773 ATAC-seq_2d-3 ATAC-seq_2d
- GSM8081774 ATAC-seq_6d-1 ATAC-seq_6d
- GSM8081775 ATAC-seq_6d-2 ATAC-seq_6d
- GSM8081776 ATAC-seq_n8d-1 ATAC-seq_n8d
- GSM8081777 ATAC-seq_n8d-2 ATAC-seq_n8d
- GSM8081778 ATAC-seq_n14d-1 ATAC-seq_n14d
- GSM8081779 ATAC-seq_n14d-2 ATAC-seq_n14d
- GSM8081780 ATAC-seq_n20d-1 ATAC-seq_n20d
- GSM8081781 ATAC-seq_n20d-2 ATAC-seq_n20d
- GSM8081782 ATAC-seq_n24d-1 ATAC-seq_n24d
- GSM8081783 ATAC-seq_n24d-2 ATAC-seq_n24d
- GSM8081784 ATAC-seq_n24d+dox-1 ATAC-seq_n24d+dox
- GSM8081785 ATAC-seq_n24d+dox-2 ATAC-seq_n24d+dox
- GSM8081786 ATAC-seq_niPSC-T-1 ATAC-seq_niPSC-T
- GSM8081787 ATAC-seq_niPSC-T-2 ATAC-seq_niPSC-T
- GSM8081788 ATAC-seq_p8d-1 ATAC-seq_p8d
- GSM8081789 ATAC-seq_p8d-2 ATAC-seq_p8d
- GSM8081790 ATAC-seq_p14d-1 ATAC-seq_p14d
- GSM8081791 ATAC-seq_p14d-2 ATAC-seq_p14d
- GSM8081792 ATAC-seq_p20d-1 ATAC-seq_p20d
- GSM8081793 ATAC-seq_p20d-2 ATAC-seq_p20d
- GSM8081794 ATAC-seq_p24d-1 ATAC-seq_p24d
- GSM8081795 ATAC-seq_p24d-2 ATAC-seq_p24d
- GSM8081796 ATAC-seq_p24d+dox-1 ATAC-seq_p24d+dox
- GSM8081797 ATAC-seq_p24d+dox-2 ATAC-seq_p24d+dox
- GSM8081798 ATAC-seq_piPSC-T-1 ATAC-seq_piPSC-T
- GSM8081799 ATAC-seq_piPSC-T-2 ATAC-seq_piPSC-T
- GSE97680 Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [ATAC-seq] 17 samples shares reprogramming, atac-seq
- GSE308846 Reprogramming lineage features promotes epithelial behavior in carcinoma cells [ATAC-seq] 6 samples shares reprogramming, atac-seq
- GSE287613 p53 safeguards chemical reprogramming of human somatic cells towards pluripotency. 63 samples shares reprogramming, pluripotency
- GSE339365 Genome-wide H3K4me3 profiling of circulating immune cells reveals dynamic epigenetic reprogramming during acute critical COVID-19 120 samples shares reprogramming
- GSE239270 Investigate FOXA2, NKX2-1, CTCF and P300 cistrome and enhancer (H3K27ac and H3k4me1) reprogramming during NEPC transformation by ChIP-seq. 104 samples shares reprogramming
- GSE280280 Reprogramming of Cellular Plasticity via ETS and MYC Core-regulatory circuits During Response to MAPK Inhibition in BRAF-mutant colorectal cancer 36 samples shares reprogramming
- GSE261321 NF-κB- and TET2-mediated macrophage reprogramming overrides the anti-inflammatory effects of hypoxia and improves responses in human cancer ChIP-Seq). 24 samples shares reprogramming
- GSE331192 Deletion of a Distal IRF4 Element Prevents Inflammation-induced Reprogramming of Human Regulatory T-cell Fate 22 samples shares reprogramming
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.